Cargando…
Opportunities for improving use of evidence‐based therapy in patients with type 2 diabetes and cardiovascular disease
Evidence‐based therapy that target hyperlipidemia, hypertension, smoking cessation, and weight loss have demonstrated significant benefits in reducing cardiovascular risks and related events. Although the benefit of intensively lowering blood glucose is unclear, newer antidiabetic drugs (glucagon‐li...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Periodicals, Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837027/ https://www.ncbi.nlm.nih.gov/pubmed/31448852 http://dx.doi.org/10.1002/clc.23252 |